Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Never forget to consider the number needed to treat

Hans Duvefelt, MD
Conditions
November 3, 2017
Share
Tweet
Share

How would you like to double your chances of winning the lottery? Just buy two tickets!

Statistically, this is true, but is that a reason to spend more money on something that most likely offers no return on investment?

Yet, in medical research, study after study shows impressive improvement in relative risk for this, that and the other intervention but a small or even negligible effect on absolute risk.

For example, I just read a study in the New England Journal of Medicine comparing giving a new osteoporosis drug to women with osteoporosis and a prior history of an osteoporotic fracture for one year, followed by an older drug for one year to just giving the older drug for two years. The two drug regimen lowered an osteoporotic woman’s risk of hip fracture by 38 percent.

The number of hip fractures in the combination treatment group was 41 out of 2046 patients, and in the single drug group, it was 66 out of 2047 patients.

In absolute numbers, treating 2046 patients reduced the hip fracture risk by 25 cases. The number of women one would need to treat to avoid one hip fracture, the number needed to treat (NNT), is 2046 divided by 25, or 81.

That NNT isn’t terribly impressive, especially in light of the fact that 12 more patients in the new drug group had a cardiovascular event in the first year than in the old drug group.

The editorial accompanying this article does say “In sum, ARCH revealed that romosozumab has great potential as a short-term anabolic treatment for osteoporosis. However, until the cardiovascular and endocrine effects of this antibody are clarified, romosozumab will remain more a part of our expectations than our armamentarium.” But if the drug company starts promoting the relative risk reduction of this treatment, doctors could be misled, and patients could come to harm.

Here are some more examples of he number needed to treat for some common health interventions, published in a post I wrote 7 years ago:

  1. Shingles vaccine doses given in order to avoid one case of shingles: 59
  2. Ear infections treated with amoxicillin to avoid one ruptured eardrum: 20
  3. Cortisone shots to relieve one sore shoulder: 3
  4. Aspirin prescriptions to prevent one heart attack: 200
  5. Prostate cancers treated in order to prevent one death: 18 to 48 (most men with prostate cancer don’t die from their disease)
  6. Adenomatous colon polyps removed to prevent one colon cancer: 50 (only 2 percent of “precancerous polyps” actually turn into cancer)

May I never forget to consider the NNT.

“A Country Doctor” is a family physician who blogs at A Country Doctor Writes:.

Image credit: Shutterstock.com

Prev

Freestanding ERs and retail clinics: Do they create a more efficient health care system?

November 3, 2017 Kevin 10
…
Next

One nurse for 4,000 pupils isn't the healthiest arrangement

November 3, 2017 Kevin 0
…

ADVERTISEMENT

Tagged as: Endocrinology

Post navigation

< Previous Post
Freestanding ERs and retail clinics: Do they create a more efficient health care system?
Next Post >
One nurse for 4,000 pupils isn't the healthiest arrangement

ADVERTISEMENT

More by Hans Duvefelt, MD

  • The art of asking where it hurts

    Hans Duvefelt, MD
  • Thinking like a plumber when adjusting medications

    Hans Duvefelt, MD
  • The American food conspiracy

    Hans Duvefelt, MD

Related Posts

  • Doctors: Never forget the importance of eye contact

    Suneel Dhand, MD
  • The CDC word ban: an attack on the patients I treat

    Rachel Alinsky, MD
  • To treat future COVID variants, we need more than vaccines

    Ian Chan, MBA
  • Using low-dose naltrexone to treat pain

    Alex Smith
  • The way we treat young doctors is barbaric

    David Penner
  • The scents in the hospital are from diseases you’ll never forget

    Yoo Jung Kim, MD

More in Conditions

  • Rethinking stimulants for ADHD

    Carrie Friedman, NP
  • Why young people need to care about bone health now

    Surgical Fitness Research Pod & Yoshihiro Katsuura, MD
  • Why health care needs empathy, not just algorithms

    Muhammad Abdullah Khan
  • A doctor’s story of IV ketamine for depression

    Dee Bonney, MD
  • Why you should get your Lp(a) tested

    Monzur Morshed, MD and Kaysan Morshed
  • Is modern medicine losing its soul?

    Michele Luckenbaugh
  • Most Popular

  • Past Week

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • The psychological trauma of polarization

      Farid Sabet-Sharghi, MD | Physician
    • Why CPT coding ambiguity harms doctors

      Muhamad Aly Rifai, MD | Physician
    • Why physicians must not suffer in silence [PODCAST]

      The Podcast by KevinMD | Podcast
    • Is Lp(a) testing the new messiah?

      Larry Kaskel, MD | Conditions
  • Past 6 Months

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • A doctor’s letter from a federal prison

      L. Joseph Parker, MD | Physician
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
  • Recent Posts

    • Rethinking stimulants for ADHD

      Carrie Friedman, NP | Conditions
    • Why young people need to care about bone health now

      Surgical Fitness Research Pod & Yoshihiro Katsuura, MD | Conditions
    • What burnout does to your executive function

      Seleipiri Akobo, MD, MPH, MBA | Physician
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • Why physicians must lead the vetting of medical AI [PODCAST]

      The Podcast by KevinMD | Podcast
    • Dealing with physician negative feedback

      Jessie Mahoney, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 7 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • The psychological trauma of polarization

      Farid Sabet-Sharghi, MD | Physician
    • Why CPT coding ambiguity harms doctors

      Muhamad Aly Rifai, MD | Physician
    • Why physicians must not suffer in silence [PODCAST]

      The Podcast by KevinMD | Podcast
    • Is Lp(a) testing the new messiah?

      Larry Kaskel, MD | Conditions
  • Past 6 Months

    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • A doctor’s letter from a federal prison

      L. Joseph Parker, MD | Physician
    • The high cost of PCSK9 inhibitors like Repatha

      Larry Kaskel, MD | Conditions
  • Recent Posts

    • Rethinking stimulants for ADHD

      Carrie Friedman, NP | Conditions
    • Why young people need to care about bone health now

      Surgical Fitness Research Pod & Yoshihiro Katsuura, MD | Conditions
    • What burnout does to your executive function

      Seleipiri Akobo, MD, MPH, MBA | Physician
    • The paradox of primary care and value-based reform

      Troyen A. Brennan, MD, MPH | Policy
    • Why physicians must lead the vetting of medical AI [PODCAST]

      The Podcast by KevinMD | Podcast
    • Dealing with physician negative feedback

      Jessie Mahoney, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Never forget to consider the number needed to treat
7 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...